secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kodiak Sciences Inc. (KOD)
CIK:        0001468748
Form:       8-K
Filed at:   2021-07-23T23:59:59+00:00
Accession:  0000950170-21-000510
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kodiak Sciences avoids $125M royalty-draw; reduces royalty cap to $450M
-----------------------------------------------------------------------

- Company and BBA agreed not to fund second $125M tranche of royalty financing agreement.
- Royalty cap reduced from $1,012.5M to $450M (4.5x the $100M already funded).
- Decision driven by strong balance sheet after $612M capital raise in Nov 2020 and clinical progress.
- Independent board committee ratified the decision.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1468748/000095017021000510/0000950170-21-000510-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1468748/000095017021000510/kod-20210721.htm
  HTML page:      https://secwatch.observer/filing/0000950170-21-000510

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer